✦ LIBER ✦

Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer

✍ Scribed by M. L. Slevin; V. J. Harvey; P. F. M. Wrigley; J. M. Gilbert; K. Hellmann; M. Evans; P. G. Cassell; B. Stoodley; H. Ellis; C. Wastell

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant oral razoxane (ICRF-159) in res

✍ J. M. Gilbert; K. Hellmann; M. Evans; P. G. Cassell; B. Stoodley; H. Ellis; C. W 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 576 KB

Randomized trial of oral adjuvant razoxa

✍ Mr. J. M. Gilbert; K. Hellmann; Margaret Evans; P. G. Cassell; R. H. Taylor; B. 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 570 KB

The value of follow-up in resectable col

✍ Urruticoechea, A.; Navarro, M.; Majem, M.; Pareja, L.; Martí-Ragué, J.; Figueras 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 163 KB